# Session summary and takeover plan — 2026-07-17

## Outcome so far

This session corrected the public site's scientific claims, published the
updated site, added a safe Cloudflare Pages workflow, verified production, and
completed a desktop/mobile UI audit. The user then approved implementing the
anti-slop recommendations and requested a complete Markdown handover.

The analytics engine was not changed. The user selected revised theme 2,
**Graphite Dark**, and the redesign is now implemented in the authoring source
and synchronized deploy artifact.

## Published work

| Item | Result |
|---|---|
| Public accuracy fixes | PR #5 merged; commit `430a6b5` |
| Cloudflare deployment workflow | PR #6 merged; commit `e8f4b66` |
| Graphite Dark redesign | PR #7 merged; commit `3f2b5bf` |
| GitHub release | `v1.0.4`, published 2026-07-17 |
| Live site | https://openpharmastability.pages.dev |
| Latest verified deployment | GitHub Actions run `29590938841`; preview `https://8fdcfa96.openpharmastability.pages.dev` |
| Deployment source | branch `main`, commit `3f2b5bf` |
| Production verification | Canonical and preview URLs return HTTP 200; remote HTML SHA-256 exactly matches LF-normalized `site/index.html` |

PR links:

- https://github.com/priyamthakar/OpenPharmaStability/pull/5
- https://github.com/priyamthakar/OpenPharmaStability/pull/6
- https://github.com/priyamthakar/OpenPharmaStability/pull/7
- https://github.com/priyamthakar/OpenPharmaStability/releases/tag/v1.0.4

## Scientific truth fixed on the public site

The golden assay case is:

- 42 rows;
- 3 batches;
- 7 time points: 0, 3, 6, 9, 12, 18, and 24 months;
- common slope with batch-specific intercepts;
- slope-interaction p-value `0.9056`;
- batch-intercept p-value approximately `1.658e-16`;
- statistical crossing approximately `17.954842` months;
- supported shelf life `17` months;
- governing batch `B2`;
- no extrapolation beyond observed coverage.

The public site and multi-attribute sample links were aligned to those facts.

## Verification completed

- Repaired `.venv` to Python 3.11.15 and installed development dependencies.
- Full suite passed: 483 collected tests, with 4 expected host-dependent PDF
  skips in the verified environment.
- `python tools/regen_expected.py --check` passed.
- Local and production Playwright QA passed for desktop/mobile navigation,
  truth copy, warnings, JSON view, and sample HTML/JSON/plot links.
- Production returned HTTP 200 and matched the local deploy artifact exactly.

## Cloudflare state

- Pages project: `openpharmastability`.
- Project type: Direct Upload; it cannot be converted in place to Git
  integration.
- Local Wrangler OAuth is authenticated and has Pages write access.
- `.github/workflows/pages-deployment.yml` exists and its sync check passed.
- GitHub repository variable `CLOUDFLARE_ACCOUNT_ID` is configured.
- GitHub secret `CLOUDFLARE_API_TOKEN` is configured with account-scoped
  `Cloudflare Pages: Edit` permission.
- Workflow run `29590938841` verified the deploy-folder sync and completed an
  unattended production deployment successfully.
- Do not store the short-lived local Wrangler OAuth token in GitHub Actions.
- Interactive maintenance remains available with local Wrangler OAuth:

```powershell
node tools/sync-site.mjs
git diff --exit-code -- site
npx -y wrangler@latest pages deploy site `
  --project-name=openpharmastability `
  --branch=main
```

## UI audit conclusion

The site is functionally good but visually over-authored. It presents internal
portfolio/design material before the scientific result. The user explicitly
wants the anti-slop recommendations implemented.

Read in this order:

1. `HANDOVER.md` current takeover state
2. `UI_UX_AUDIT.md`
3. `DESIGN.md`
4. `NEXT_STEPS.md` §11
5. `README.md` public website and deployment sections

## Published documentation set

The following documentation files were reviewed and published as one set with
the Graphite Dark redesign:

- `HANDOVER.md`
- `NEXT_STEPS.md`
- `README.md`
- `DESIGN.md`
- `UI_UX_AUDIT.md`
- `SESSION_SUMMARY_2026-07-17.md`
- `CMC_ANALYTICS_POSITIONING.md`
- `CHANGELOG.md`

Do not edit `AGENTS.md`; it is an archived v0.1 build plan and says it is
read-only. Do not rewrite `OpenPharmaStability.md` for the website redesign;
its analytical product behavior remains authoritative and unchanged.

## Redesign implementation completed locally

- Selected reference: `design-concepts/revised-theme-2-graphite-dark.png`.
- Implemented a single evidence-led page with Graphite Dark tokens, IBM Plex
  typography, direct navigation, real sample plot, model ledger, scope limits,
  local-execution explanation, and CLI commands.
- Removed the public App UI and Design System views and portfolio/hiring copy.
- Rewrote `tools/website-qa.mjs` for the new information architecture.
- Desktop and mobile QA pass with zero horizontal overflow and no console or
  component errors; all sample artifact links return HTTP 200.
- Side-by-side visual comparison is saved at
  `qa-output/design-comparison-desktop.png`; `design-qa.md` records the pass.

## Exact next work

The implementation and release gates are complete:

- Full pytest suite passed: 483 collected with 4 expected host-dependent PDF
  skips.
- `python tools/regen_expected.py --check` passed.
- Latest automated production deployment: GitHub Actions run `29590938841`.
- Deployment preview: https://8fdcfa96.openpharmastability.pages.dev
- Canonical site: https://openpharmastability.pages.dev
- Both URLs return HTTP 200; the Graphite Dark content had already passed
  desktop/mobile website QA before the automated redeploy.
- Production and LF-normalized local `site/index.html` SHA-256 match:
  `9348cc241acb58234f570df4ec9ac87b12a8af5c37f0423e776da0adb32b1232`.

Post-release state: PR #7 is merged, `v1.0.4` is published, and automated Pages
deployment is operational. The optional public sample PDF is the next small
website enhancement; do not start a hosted analysis backend without a separate
product decision.

## Redesign guardrails

- Do not reimplement statistics in JavaScript.
- Do not change the golden numbers or regulatory disclaimer.
- Do not imply the static site runs analyses.
- Do not replace one generic template with another.
- Use real report/plot evidence, not a fabricated dashboard.
- Remove public design-system and hiring-process language.
- Preserve all sample report/JSON/plot links.
- Treat mobile as a content-prioritization problem, not just a stacking problem.
